Arch Biopartners Market Cap

Arch Biopartners has a market cap or net worth of $25.81 million as of March 26, 2026. Its market cap has decreased by -69.75% in one year.

Market Cap

25.81M

Enterprise Value

27.73M

Revenue

115.29K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.39

Market Cap Chart

Since January 21, 2011, Arch Biopartners's market cap has decreased from 33.63M to 25.81M, a decrease of -23.24%. That is a compound annual growth rate of -1.73%.

Market Cap History

Date	Market Cap	% Change
Mar 25, 2026	25.81M	-56.35%
Dec 31, 2025	59.13M	-32.56%
Dec 31, 2024	87.67M	25.12%
Dec 29, 2023	70.07M	-46.02%
Dec 30, 2022	129.79M	-23.83%
Dec 31, 2021	170.40M	138.05%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 26, 2019	Upgrade Pro	Upgrade Pro
Dec 26, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 23, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Vicapsys Life Sciences	48.56M
Anebulo Pharmaceuticals	41.60M
Cell Source	37.29M
ZIVO Bioscience	33.01M
Harvard Apparatus Regenerative Technology	29.49M
Provectus Biopharmaceuticals	21.41M
NKGen Biotech	20.90M
Zenith Capital	20.77M

Market Cap Rankings